AzTrials
AzTrials

Kidney TransplantTASKNCT05151445

The Use of a Consumer-Based mHealth Dietary App and Health Coaching With Kidney Transplant Recipients

An observational study of Kidney Transplant and Kidney Transplant; Complications, run by Ohio State University at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of the study is to test the feasibility mHealth dietary app + health coaching for improving primary outcomes (recruitment, retention, and adherence) and secondary outcomes (perceived stress [ Perceived Stress Scale], exercise self-efficacy[Exercise Self-efficacy Scale], vegetable intake [Fruit, Vegetables… Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
mHealth dietary app + health coaching intervention
How many people
20 participants
Where
1 siteUnited States
Study dates
1 Mar 2021to 31 Dec 2023
Phase
Observational
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: The participants will be recruited or contacted from a list of kidney recipients that have already requested they be contacted for future studies from our previous study. This list consists of approximately 60 people.

Who may be able to join

  • age 18 or older men and women
  • functioning KTR (not on dialysis)
  • ability to speak, read, and hear English,
  • possession of a smartphone capable of accessing and downloading a mHealth dietary app
  • Wi-Fi or Internet access,
  • greater than 3 months post-transplant (due to medication adjustments and decreased functional levels),
  • not hospitalized
  • capable of self-consent per capacity screening.

Who cannot join

  • Participation in a weight loss program
  • participation in a structured exercise program
  • diagnosis of dementia.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Ohio State University Medical Center

    Columbus, Ohio, 43210

Other trials in United States

About this study

The purpose of the study is to test the feasibility mHealth dietary app + health coaching for improving primary outcomes (recruitment, retention, and adherence) and secondary outcomes (perceived stress [ Perceived Stress Scale], exercise self-efficacy[Exercise Self-efficacy Scale], vegetable intake [Fruit, Vegetables, and Fiber Screen] fat intake [Lose-it Premium database], carbohydrate intake [Lose-it Premium database], weight, [Wi-Fi weight scale using the Lose-it Premium database], and blood pressure [Wi-Fi blood pressure cuff using the Lose-it Premium database].

Read the detailed description

The proposed study seeks to shift the paradigm for promoting diet intake and physical activity using education and self-report to provide a powerful combination of mHealth dietary app and health coaching (set goals, provide ongoing feedback, and self-monitor behaviors). To the investigators knowledge, this is the first time a mHealth dietary app and health coaching intervention has been used in kidney transplant recipients to link real-time data for monitoring dietary intake and physical activity.

The long-term goal of this work is to enhance well-being in kidney recipients via lifestyle self-management of care for dietary intake and physical activity to ultimately prevent chronic diseases. The proposed study is important because early weight gain after kidney transplant is associated with adverse effects on the transplanted kidney function resulting in increased health care cost and poor quality of life. Interventions are needed to monitor kidney transplant recipients diet and physical activity in real-time to prevent health decline.

Being tested
mHealth dietary app + health coaching intervention

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • mHealth dietary app + health coaching interventionBehavioural

    The "Lose-It" app will be set up with Gmail accounts with unique unidentifiable codes developed by the research team. Participants be trained to enter their dietary intake and physical activity daily for 12-weeks. Participants will monitor their vegetable intake, fat intake, carbohydrate intake, weight, and blood pressure. Wi-Fi connected weight scales and blood pressure cuff will be supplied for weight and blood pressure monitoring. Participants will be taught how to sync the data from the scales and blood pressure cuff to the app for the research team to access. Participants will perform a return demonstration to confirm that they can record their dietary intake daily, physical activity, weight, and blood pressure using the "Lose-It" app. We also review with the participant the "My Plate" method for proper nutrition and the steps to distance conversion chart.

Study groups in NCT05151445
Study groupRoleWhat they receive
mHealth dietary app + health coaching interventionA feasibility study will be utilized to establish the recruitment, retention, and adherence with post-kidney transplant recipients using a consumer-based mHealth dietary app + health coaching.
Receives: Behavioral: mHealth dietary app + health coaching intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The Feasibility of the Study Recruitment for the Study

    Recruitment (percent of participants approached to be in the study), will be recorded by the research assistant.

    Measured: Baseline

  2. The Feasibility of Participant Retention for the Study

    Retention (percent of participants that dropped during the study), will be recorded by the research assistant.

    Measured: Assessed at Baseline, 4 weeks, 8 weeks, and 12 weeks

  3. The Feasibility of Adherence for Using the Lose- It App to Record Diet

    Adherence (percent to adhere to logging daily dietary intake) will be recorded continuously each day by the "Lose-It" app.

    Measured: Weekly for 12 weeks

  4. The Feasibility of Adherence for Using the Lose- It App to Physical Actvity

    Adherence (percent to adhere to logging daily physical activity) will be recorded continuously each day by the "Lose-It" app.

    Measured: Weekly for 12 weeks

Secondary outcomes (9)
  1. Perceived Stress Level

    Perceived Stress Scale will be evaluated by using the Perceived Stress Scale (PSS).The PSS is a 10-item questionnaire using a Likert Scale to rate feelings of stress from 0 "never" to 4 "very often." Individual scores on the PSS can range from 0 to 40 with higher scores indicating higher perceived stress.

    Measured: Assessed at Baseline, 4 weeks, 8 weeks, and 12 weeks

  2. Exercise Self-Efficacy

    Exercise Self-Efficacy Scale will be evaluated by using the Self-Efficacy for Exercise (SEE) Scale. The SEE is a 9-item questionnaire using a Likert Scale to rate feelings of stress from 0 "not confident" to 10 "very confident." This scale has a range of total scores from 0-90. A higher score indicates higher self-efficacy for exercise.

    Measured: Assessed at Baseline, 4 weeks, 8 weeks, and 12 weeks

  3. Fruit and Vegetable Servings Per Day

    Fruit and vegetable intake will be assessed using the Fruit, Vegetable and Fiber Screen which uses a scale to assess fruit and vegetable intake using a Likert Scale to rate intake from less than1/ per week to more than 2 a day. Higher scores indicate that more fruits and vegetables are being consumed by participants.

    Measured: Assessed at Baseline, 4 weeks, 8 weeks, and 12 weeks

  4. Fiber Intake

    Fiber intake will be assessed using the Fruit, Vegetable and Fiber Screen which uses a scale to assessfiber intake using a Likert Scale to rate intake from less than1/ per week to more than 2 a day.Higher scores indicate more fiber intake.

    Measured: Assessed at Baseline, 4 weeks, 8 weeks, and 12 weeks

  5. Fat Intake

    The participant will record their percent of fat intake each day into the Lose-it Premium application.

    Measured: Assessed at Baseline, 4 weeks, 8 weeks, and 12 weeks

  6. Carbohydrate Intake

    The participant will record their percent of carbohydrate intake each day into the Lose-it Premium application.

    Measured: Assessed at Baseline, 4 weeks, 8 weeks, and 12 weeks

  7. Weight

    Weight (pounds) will be measured each day by the participant using a wireless Wi Fi weight scale. The data from the wireless weight scale will sync the data from the participant's mobile phone to the premium password-protect "Lose-It" database each day.

    Measured: Assessed at Baseline, 4 weeks, 8 weeks, and 12 weeks

  8. Systolic Blood Pressure

    Systolic blood pressure (millimeters of mercury [mmHg]) will be recorded each day by the participant using a wireless Wi Fi blood pressure cuff. The data from the wireless cuff will sync from the participant's mobile phone to the premium password-protect "Lose-It" database each day.

    Measured: Assessed at Baseline, 4 weeks, 8 weeks, and 12 weeks

  9. Diastolic Blood Pressure

    Systolic blood pressure (millimeters of mercury [mmHg]) will be recorded each day by the participant using a wireless Wi Fi blood pressure cuff. The data from the wireless cuff will sync from the participant's mobile phone to the premium password-protect "Lose-It" database each day.

    Measured: Assessed at Baseline, 4 weeks, 8 weeks, and 12 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Dec 2021
  2. Study start1 Mar 2021
  3. Primary completion1 Jan 2023
  4. Study completion31 Dec 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Prospective
Enrolment
20 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05151445
Sponsor's protocol ID
2020B0261
Acronym
TASK
Status last verified
Aug 2024
First submitted
9 Nov 2021
Last updated
28 Oct 2024
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Conte C, Secchi A. Post-transplantation diabetes in kidney transplant recipients: an update on management and prevention. Acta Diabetol. 2018 Aug;55(8):763-779. doi: 10.1007/s00592-018-1137-8. Epub 2018 Apr 4.

    PubMed 29619563
  • Aksoy N. Weight Gain After Kidney Transplant. Exp Clin Transplant. 2016 Nov;14(Suppl 3):138-140.

    PubMed 27805534
  • Zelle DM, Kok T, Dontje ML, Danchell EI, Navis G, van Son WJ, Bakker SJ, Corpeleijn E. The role of diet and physical activity in post-transplant weight gain after renal transplantation. Clin Transplant. 2013 Jul-Aug;27(4):E484-90. doi: 10.1111/ctr.12149. Epub 2013 Jun 13.

    PubMed 23758229
  • Workeneh B, Moore LW, Nolte Fong JV, Shypailo R, Gaber AO, Mitch WE. Successful Kidney Transplantation Is Associated With Weight Gain From Truncal Obesity and Insulin Resistance. J Ren Nutr. 2019 Nov;29(6):548-555. doi: 10.1053/j.jrn.2019.01.009. Epub 2019 Mar 7.

    PubMed 30852120
  • Rosenberger J, Geckova AM, Dijk JP, Roland R, Heuvel WJ, Groothof F JW. Factors modifying stress from adverse effects of immunosuppressive medication in kidney transplant recipients. Clin Transplant. 2005 Feb;19(1):70-6. doi: 10.1111/j.1399-0012.2004.00300.x.

    PubMed 15659137
  • Klaassen G, Zelle DM, Navis GJ, Dijkema D, Bemelman FJ, Bakker SJL, Corpeleijn E. Lifestyle intervention to improve quality of life and prevent weight gain after renal transplantation: Design of the Active Care after Transplantation (ACT) randomized controlled trial. BMC Nephrol. 2017 Sep 15;18(1):296. doi: 10.1186/s12882-017-0709-0.

    PubMed 28915863
  • Kim IK, Choi SH, Son S, Ju MK. Early Weight Gain After Transplantation Can Cause Adverse Effect on Transplant Kidney Function. Transplant Proc. 2016 Apr;48(3):893-6. doi: 10.1016/j.transproceed.2015.10.064.

    PubMed 27234761
  • Edwards ES, Sackett SC. Psychosocial Variables Related to Why Women are Less Active than Men and Related Health Implications. Clin Med Insights Womens Health. 2016 Jul 4;9(Suppl 1):47-56. doi: 10.4137/CMWH.S34668. eCollection 2016.

    PubMed 27398045
  • Hap K, Madziarska K, Hap W, Zmonarski S, Zielinska D, Kaminska D, Banasik M, Koscielska-Kasprzak K, Klinger M, Mazanowska O. Are Females More Prone Than Males to Become Obese After Kidney Transplantation? Ann Transplant. 2019 Jan 29;24:57-61. doi: 10.12659/AOT.912096.

    PubMed 30737367
  • Pedrollo EF, Nicoletto BB, Carpes LS, de Freitas JMC, Buboltz JR, Forte CC, Bauer AC, Manfro RC, Souza GC, Leitao CB. Effect of an intensive nutrition intervention of a high protein and low glycemic-index diet on weight of kidney transplant recipients: study protocol for a randomized clinical trial. Trials. 2017 Sep 6;18(1):413. doi: 10.1186/s13063-017-2158-2.

    PubMed 28874181
  • Wilcox J, Waite C, Tomlinson L, Driscoll J, Karim A, Day E, Sharif A. Comparing glycaemic benefits of Active Versus passive lifestyle Intervention in kidney Allograft Recipients (CAVIAR): study protocol for a randomised controlled trial. Trials. 2016 Aug 22;17(1):417. doi: 10.1186/s13063-016-1543-6.

    PubMed 27550305
  • Clunk JM, Lin CY, Curtis JJ. Variables affecting weight gain in renal transplant recipients. Am J Kidney Dis. 2001 Aug;38(2):349-53. doi: 10.1053/ajkd.2001.26100.

    PubMed 11479161
  • Aminu MS, Sagren N, Manga P, Nazir MS, Naicker S. Obesity and graft dysfunction among kidney transplant recipients: Increased risk for atherosclerosis. Indian J Nephrol. 2015 Nov-Dec;25(6):340-3. doi: 10.4103/0971-4065.151358.

    PubMed 26664208
  • Williams-Hooker R, Draper CM, Chen L, Mitchell CO, Cashion AK. The relationship between fruit and vegetable consumption and weight gain in kidney transplant recipients within 1 year posttransplant. Top Clin Nutr. 2015;30(4):324-332.

  • Mellen PB, Gao SK, Vitolins MZ, Goff DC Jr. Deteriorating dietary habits among adults with hypertension: DASH dietary accordance, NHANES 1988-1994 and 1999-2004. Arch Intern Med. 2008 Feb 11;168(3):308-14. doi: 10.1001/archinternmed.2007.119.

    PubMed 18268173

Questions about this trial

What is this clinical trial studying?

An observational study of Kidney Transplant and Kidney Transplant; Complications, run by Ohio State University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 28 Oct 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 28 Oct 2024). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The Feasibility of the Study Recruitment for the Study (time frame: Baseline). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05151445, which also lists 36 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Oct 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in